[Microsomal triglyceride transfer protein inhibitor].
Sugimoto
T
T
Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University.
Yamashita
S
S
D000818:Animals; D001055:Apolipoproteins B / Q000378:metabolism; D001161:Arteriosclerosis / Q000209:etiology / Q000517:prevention & control; D002352:Carrier Proteins / Q000037:antagonists & inhibitors* / Q000502:physiology; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy / Q000209:etiology; D007211:Indoles / Q000494:pharmacology / Q000627:therapeutic use*; D054833:Isoindoles; D008079:Lipoproteins, VLDL / Q000378:metabolism; D008702:Methaqualone / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use*; D010880:Piperidines / Q000494:pharmacology / Q000627:therapeutic use*
C102576:4-bromomethaqualone; D001055:Apolipoproteins B; C101970:BMS 200150; D002352:Carrier Proteins; D007211:Indoles; D054833:Isoindoles; D008079:Lipoproteins, VLDL; D010880:Piperidines; C106092:microsomal triglyceride transfer protein; D008702:Methaqualone